Evidence map›Paper›PMID 32977807›Full record

ArticleRadiation oncology (London, England)2020

A unique radioprotective effect of resolvin E1 reduces irradiation-induced damage to the inner ear by inhibiting the inflammatory response.

Jie Zhang, Anting Xu, Tingting Niu, Chengcheng Liu, Yongju Zhang, Tao Li, Jihua Wang, Yongjing Wang, Dianshui Sun

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jie ZhangDepartment of Otolaryngology & NHC Key Laboratory of Otorhinolaryngology, the Second Hospital of Shandong University, Jinan, 250033, Shandong Province, China.
Anting XuDepartment of Otolaryngology & NHC Key Laboratory of Otorhinolaryngology, the Second Hospital of Shandong University, Jinan, 250033, Shandong Province, China.
Tingting NiuDepartment of Medical Technology, the Jinan Vocational College of Nursing, Jinan, 250102, Shandong Province, China.
Chengcheng LiuDepartment of Otolaryngology & NHC Key Laboratory of Otorhinolaryngology, the Second Hospital of Shandong University, Jinan, 250033, Shandong Province, China.
Yongju ZhangDepartment of Otolaryngology & NHC Key Laboratory of Otorhinolaryngology, the Second Hospital of Shandong University, Jinan, 250033, Shandong Province, China.
Tao LiDepartment of Otolaryngology & NHC Key Laboratory of Otorhinolaryngology, the Second Hospital of Shandong University, Jinan, 250033, Shandong Province, China.
Jihua WangCancer Center, the Second Hospital of Shandong University, No.247 Beiyuan Road, Jinan, 250033, Shandong Province, China.
Yongjing WangDepartment of Hematology, the Second Hospital of Shandong University, Jinan, 250033, Shandong Province, China.
Dianshui SunCancer Center, the Second Hospital of Shandong University, No.247 Beiyuan Road, Jinan, 250033, Shandong Province, China. sundianshui@163.com.ORCID http://orcid.org/0000-0003-2758-0511
Second Hospital of Shandong University · CNJinan Maternity And Care Hospital · CN

Funding

Clinical Medical Science and Technology Innovation Plan of Jinan City 201704089National Natural Science Foundation of China 81641033Natural Science Foundation of Shandong Province ZR2019MH017
6 · The paper itself

Abstract

backgroundIn addition to the direct effects of irradiation, the induced inflammatory response may play an important role in the damage to the inner ear caused by radiotherapy for the treatment of head and neck cancers. Resolvin E1 (RvE1) has anti-inflammatory activity, acting by reducing neutrophil infiltration and proinflammatory cytokine expression. Therefore, in this study we sought to confirm whether the inflammation induced by irradiation was involved in damage to the inner ear after radiotherapy and to investigate the protective effect and underlying mechanism of RvE1 using mouse models.

methodsA dose of RvE1 was delivered by intraperitoneal injection to mice before irradiation. Changes in the auditory brainstem response (ABR), relative balance ability, inner ear morphology and the expression levels of inflammatory factors in the inner ear were analyzed on days 7 and 14 after irradiation and compared among different experimental groups.

resultsChanges of ABR and relative balance ability showed the inner functions of experimental mice presented severe damage after irradiation, but the damage was significantly alleviated after RvE1 pretreatment compared to irradiation alone. Morphological analysis of the inner ear showed severe damage to the cochlea and vestibule after irradiation. In contrast, damage to the cochlea and vestibule was significantly reduced in the RvE1-pretreated group compared to that in the irradiation alone group. Along with these functional and morphological changes, the mRNA expression level of anti-inflammatory factors interleukin-2 was significantly increased, while those of proinflammatory factors interleukin-6 and tumor necrosis factor-α were significantly decreased in the inner ear of mice after RvE1 pretreatment compared to irradiation alone.

conclusionsWe believe that inflammation induced by irradiation is involved in the damage to the inner ear caused by radiotherapy, and that RvE1 reduces the damage caused by irradiation to the inner ear by regulating the induced inflammatory response.

Indexed as

AnimalsEar, InnerEicosapentaenoic AcidFemaleInflammationMiceMice, Inbred C57BLRadiation-Protective AgentsX-Rays5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acidEicosapentaenoic AcidRadiation-Protective AgentsInflammatory responseInner earProinflammatory cytokineRadioprotective effectResolvin E1

Identifiers

PMID32977807
PMCPMC7517621
OpenAlexW3088625953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.